Regulatory Filings • Jan 26, 2017
Regulatory Filings
Open in ViewerOpens in native device viewer
_________ false
| �������� ��������� ���� | 2 381 |
| PLURISTEM THERAPEUTICS INC | |
| Corporation no: C12337-2001 | 8544 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C003 ( Public ) | Reported via MAGNA: | 25/01/2017 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2017-02-008530 | Time of broadcast: 23:25 23:14:42 |
Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.
| Attached hereto is a report on | Pluristem Announces Closing of Bought Offering and Underwriter�s Exercise in Full of Over-Allotment Option |
Pluristem_-_PR_closing_final_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: NASDAQ CM | Date of revision of form structure: 29/12/2016 |
| Address: Matam Park 5 , Haifa 31905 ISRAEL , Tel: 074-7107171 , Fax: 074-7107172 | |
| E-mail address: [email protected] Company site: www.pluristem.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: Aberman Zalman Position of Signatory in the reporting corporation: Chairman Of The Board & CEO Name of Employer Company: | |
| Address: Matam Park 20 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7107172 E-mail: [email protected] 2 | |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.